1-11 of 11
Peter Mollee, FRACP,MBBS,MSc,FRCPA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Use of Monocyte Subset Repartitioning By Flow Cytometry for Diagnosis of Chronic Myelomonocytic Leukemia

Aarya Murali, MBBS (Hons), Donna Cross, Peter Mollee, FRACP,MBBS,MSc,FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-140966
Published: 2020
Journal Articles

A Randomized Study of Bortezomib, Cyclophosphamide and Dexamethasone Induction (VCD) Versus VCD and Daratumumab Induction Followed By Daratumumab Maintenance (VCDD) for the Initial Treatment of Transplant-Ineligible Patients with Multiple Myeloma (AMaRC 03-16)

Peter Mollee, FRACP,MBBS,MSc,FRCPA, John Reynolds, PhD, Wojt Janowski, FRCPA,FRACP, Hang Quach, MDFRACP,FRCPA,MBBS, Philip Campbell, MBBS, Simon D. Gibbs, FRACP, FRCPA, MBBS, Sophie Lee, FRACP, FRCPA, PhD, James D'Rozario, MBBS, FRACP, FRCPA, Kerry Taylor, FRACP,FRCPA,MBBS, Tara Cochrane, MBBS,FRCPA,FRACP, Craig Thomas Wallington-Beddoe, BSc,MBBS,PhDFRACP,FRCPA, Fiona Kwok, FRACP,FRCPA,MBBS, Nicholas Weber, MBBS, Ian H. Kerridge, FRACP FRCPA MPhil BA, Helen Weston, MBBS, FRACP, FRCPA, Phoebe Joy Ho, MBBS,DPhil,FRACP,FRCPA, Noemi Horvath, MB ChB FRACP FRCPA, Flora Yuen, BBiomedSc, Andrew Spencer
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-138394
Published: 2020
Journal Articles

Evaluation of Minimal Residual Disease (MRD) Negativity in Patients with Relapsed or Refractory Multiple Myeloma Treated in the Candor Study

Ola Landgren, MD PhD, Katja Weisel, MD, Laura Rosinol Dachs, Philippe Moreau, MD, Mehmet Turgut, MD, Roman Hajek, MD PhD, Peter Mollee, FRACP,MBBS,MSc,FRCPA, Jin Seok Kim, MD PhD, Jianqi Zhang, Ning Go, PhD, Christopher L. Morris, PhDMD, Saad Z. Usmani, MDMBBS,MBA
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–34.
https://doi.org/10.1182/blood-2020-141291
Published: 2020
Journal Articles

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Subgroup Analysis of the Phase 3 Candor Study in Patients with Early or Late Relapse

Katja Weisel, MD, George F. Geils, MD, Lionel Karlin, MD, Peter Mollee, FRACP,MBBS,MSc,FRCPA, Tae-Hoon Chung, Chang-Ki Min, MD PhD, Kazutaka Sunami, MD PhD, Amanda Goldrick, MD, Belle Fang, Jessica Fowler, PhD, Maria-Victoria Mateos, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-133908
Published: 2020
Journal Articles

Management and Outcomes of Testicular Lymphoma in the Rituximab Era at an Australian Tertiary Centre

Aarya Murali, MBBS (Hons), Stephen Boyle, MBChB, BSc(Hons), MRCP(UK), Peter Mollee, FRACP,MBBS,MSc,FRCPA, Greg Hapgood, BMBS, FRACP, FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-138440
Published: 2020
Journal Articles

Reduction in Absolute Involved Free Light Chain and Difference between Involved and Uninvolved Free Light Chain Is Associated with Prolonged Major Organ Deterioration Progression-Free Survival in Patients with Newly Diagnosed AL Amyloidosis Receiving Bortezomib, Cyclophosphamide, and Dexamethasone with or without Daratumumab: Results from Andromeda

Raymond L. Comenzo, MD, Efstathios Kastritis, MD, Giovanni Palladini, MD PhD, Monique C. Minnema, Ashutosh D. Wechalekar, MBBS,FRCP,FRCPath,DM, Arnaud Jaccard, MD PhD, Vaishali Sanchorawala, MD, Hans C. Lee, MD, Simon D. Gibbs, FRACP, FRCPA, MBBS, Peter Mollee, FRACP,MBBS,MSc,FRCPA, Christopher P. Venner, MD, Jin Lu, Stefan Schönland, MD, Moshe Gatt, MD, Kenshi Suzuki, MD PhD, Kihyun Kim, MD PhD, M. Teresa Cibeira, MD PhD, Meral Beksac, MD, Edward Libby, MD, Jason Valent, MD, Vania T. M. Hungria, MD PhD, Sandy W. Wong, MD, Michael Rosenzweig, MD, Naresh Bumma, MD, Dominique Chauveau, MD PhD, Meletios A Dimopoulos, NamPhuong Tran, MD, Xiang Qin, MD PhD, Sandra Y. Vasey, MSc, Brenda Tromp, MSc, Brendan M. Weiss, MD, Jessica Vermeulen, MD PhD, Giampaolo Merlini, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 48–50.
https://doi.org/10.1182/blood-2020-137582
Published: 2020
Journal Articles

The Impact of S-Li-M Criteria in Myeloma in a Real-Life Population: Patient & Disease Characteristics, Treatment and Outcomes from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)

Phoebe Joy Ho, MBBS,DPhil,FRACP,FRCPA, Elizabeth M. Moore, PhD, Cameron Wellard, Hang Quach, MD, Hilary Blacklock, Simon J Harrison, MBBS MRCP (UK) PhDFRCPath (UK) FRACP, Emma-Jane McDonald, MRCP, FRCPath, Zoe McQuilten, MBBS, PhD, Erica M. Wood, MBBS, FRACP, FRCPA, Peter Mollee, FRACP,MBBS,MSc,FRCPA, Andrew Spencer
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-141511
Published: 2020
Journal Articles

The Role of Whole Body STIR MRI in Assessing First Biochemical Relapse in Patients with Myeloma

James Rowland, MBBS,BPharm, Peter Mollee, FRACP,MBBS,MSc,FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 55.
https://doi.org/10.1182/blood-2020-139194
Published: 2020
Journal Articles

A Cost-Effectiveness Analysis of Front-Line Treatment Strategies in Early Stage Follicular Lymphoma

Joshua W.D. Tobin, MD, Greg Hapgood, BMBS, FRACP, FRCPA, Maher K. Gandhi, PhDFRACP,FRCPath, Peter Mollee, FRACP,MBBS,MSc,FRCPA, Ti Ma, BSci, Anna Crothers, Paul Scuffham
Journal: Blood
Blood (2020) 136 (Supplement 1): 54–55.
https://doi.org/10.1182/blood-2020-138590
Published: 2020
Journal Articles

Health-Related Quality of Life in Patients with AL Amyloidosis Treated with Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone: Results from the Phase 3 Andromeda Study

Vaishali Sanchorawala, MD, Giovanni Palladini, MD PhD, Monique C. Minnema, Arnaud Jaccard, MD PhD, Hans C. Lee, MD, Simon D. Gibbs, FRACP, FRCPA, MBBS, Peter Mollee, FRACP,MBBS,MSc,FRCPA, Christopher P. Venner, MD, Jin Lu, Stefan Schönland, MD, Moshe Gatt, MD, Kenshi Suzuki, MD PhD, Kihyun Kim, MD, M. Teresa Cibeira, MD PhD, Meral Beksac, MD, Edward Libby, MD, Jason Valent, MD, Vania T. M. Hungria, MD PhD, Sandy W. Wong, MD, Michael Rosenzweig, MD, Naresh Bumma, MD, Dominique Chauveau, MD PhD, Katharine S. Gries, PhD PharmD, John Fastenau, RPh, MPH, PhD, NamPhuong Tran, MD, Xiang Qin, MD PhD, Sandra Y. Vasey, MSc, Brenda Tromp, MSc, Brendan M. Weiss, MD, Jessica Vermeulen, MD PhD, Giampaolo Merlini, MD, Raymond L. Comenzo, MD, Efstathios Kastritis, MD, Ashutosh D. Wechalekar, MBBS,FRCP,FRCPath,DM
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–40.
https://doi.org/10.1182/blood-2020-139438
Published: 2020
Journal Articles

Management and Outcomes of Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in the PET/CT Era: A Multicentre Study from the Australasian Lymphoma Alliance

Stephen Boyle, MBChB, BSc(Hons), MRCP(UK), Joshua W.D. Tobin, MD, Jacinta Perram, MBBS,BSc,MPH,BA, Nada Hamad, MBBS,BSc,MSc,FRACP FRCPA, Allison Barraclough, MBBS FRACP FRCPA, Lydia Singaraveloo, Min-Hi Han, MBBS, BSc, Richard Blennerhassett, Niles Elizabeth Nelson, BSc, MBBS, Anna Johnston, MBBS (Hons 1), FRACP, FRCPA, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS, Krishna Karpe, Abir Bhattacharyya, MBBS, FRACP, FRCPA, Chan Yoon Cheah, MBBS, Elango Subramoniapillai, MBBS, FRACP, Waqas Bokhari, Cindy Lee, MD, Eliza A Hawkes, FRACP,MDMBBS, Veena Gullapalli, MBBS FRACP FRCPA, Andrew Jabbour, Simone Strasser, MBBS MDFRACP FAASLD, Steve Chadban, BMed(hons), PhD FRACP, FAHMS, Christina Brown, MBBS PhDFRACP FRCPA, Peter Mollee, FRACP,MBBS,MSc,FRCPA, Greg Hapgood, BMBS, FRACP, FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–38.
https://doi.org/10.1182/blood-2020-140665
Published: 2020